Autoantigen specific IL-2 activated CD4+CD25+T regulatory cells inhibit induction of experimental autoimmune neuritis

J Neuroimmunol. 2020 Apr 15:341:577186. doi: 10.1016/j.jneuroim.2020.577186. Epub 2020 Feb 3.

Abstract

Experimental autoimmune neuritis (EAN) induced by peripheral nerve myelin (PNM) is self-limiting and re-immunization with PNM does not re-activate disease. This study showed inhibition of EAN by CD4+CD25+T cells both from sensitized hosts or from naïve hosts after ex-vivo activation by PNM and rIL-2. Transfer of naïve CD4+CD25+T cells has no effect on EAN, nor did naïve CD4+CD25+T cells activated with rIL-2 and renal tubular antigen. Culture of naive CD4+CD25+Treg with rIL-2 and PNM induced mRNA for the IFN-gamma receptor. We showed naïve CD4+CD25+T cells activated by specific auto-antigen and rIL-2 produced more potent antigen-specific Treg that may have therapeutic potential.

Keywords: Autoimmunity; Experimental autoimmune neuritis; Interleukin-2; T regulatory cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autoantigens / immunology*
  • CD4 Antigens / analysis
  • Cells, Cultured
  • Convalescence
  • Female
  • Immunotherapy, Adoptive*
  • Interleukin-2 / pharmacology*
  • Interleukin-2 Receptor alpha Subunit / analysis
  • Lymphocyte Activation / drug effects
  • Myelin Sheath / immunology
  • Neuritis, Autoimmune, Experimental / immunology*
  • Neuritis, Autoimmune, Experimental / prevention & control
  • Rats
  • Rats, Inbred Lew
  • Recombinant Proteins / pharmacology
  • Recurrence
  • T-Cell Antigen Receptor Specificity
  • T-Lymphocytes, Regulatory / immunology*
  • T-Lymphocytes, Regulatory / transplantation

Substances

  • Autoantigens
  • CD4 Antigens
  • Interleukin-2
  • Interleukin-2 Receptor alpha Subunit
  • Recombinant Proteins